|
|
Office Locations:
|
206 Bridge Street
Charlevoix, MI 49720
Phone: 231-497-1286
Fax: 231-497-1298
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
BioStar Capital is a venture capital partnership formed in 2003 by physicians and medical business leaders to invest primarily in early-stage medical devices. BioStar prefers to invest in the cardiovascular, orthopedic, neuroscience, and gastroenterology clinical specialties, but the partners are also interested in looking at biomaterials and how they can be used in any type of clinical area. If appropriate, BioStar will serve as lead investor but will participate in follow on investments as well. The firm's initial investment in a company ranges from $250K - $3 million, depending on the technology and stage of a company's development. BioStar intends to support portfolio companies in their follow-on financing rounds through time of exit. Accordingly, BioStar invests between $2-$6 million over the life of an investment. BioStar invests in companies throughout the United States and Israel. BioStar announced (December 2023) it has closed its fifth fund at $130.3 million.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
